GGrantIndex
← Leaderboards

Louis Michael Messina

University Of California San Francisco

$5,766,947
Attributed
$5,766,947
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $507.8K · FY200521
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$5,766,947 · 3

By mechanism

R01$5,306,322 · 2
R21$460,625 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of California San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsBaseArteriesHypercholesterolemiaOxidant StressBlood VesselsLimb StructureInflammatoryDiabetes MellitusImpairmentEpidemicIn VivoWild Type MouseStem CellsTetrahydrobiopterinFunctional DisorderPeripheral Arterial DiseaseCell PhysiologyNeovascularizationResponseTransplantationIschemiaAffectDisability

Grant awards (15)

Combined effects of aging and type 2 diabetes on wound healing in a humanized mouse model$209,375
R21 · FY2021 · AG · contact PI
Combined effects of aging and type 2 diabetes on wound healing in a humanized mouse model$251,250
R21 · FY2020 · AG · contact PI
Hypercholesterolemia Impairs Stem Cell-Mediated Post-Ischemic Neovascularization$418,750
R01 · FY2017 · HL · contact PI
Hypercholesterolemia Impairs Stem Cell-Mediated Post-Ischemic Neovascularization$418,750
R01 · FY2016 · HL · contact PI
Hypercholesterolemia Impairs Stem Cell-Mediated Post-Ischemic Neovascularization$412,468
R01 · FY2015 · HL · contact PI
Hypercholesterolemia Impairs Stem Cell-Mediated Post-Ischemic Neovascularization$418,750
R01 · FY2014 · HL · contact PI
Mesenchymal stem cells in the treatment of hindlimb ischemia in diabetic mice$387,595
R01 · FY2013 · HL · contact PI
Mesenchymal stem cells in the treatment of hindlimb ischemia in diabetic mice$407,138
R01 · FY2012 · HL · contact PI
Mesenchymal stem cells in the treatment of hindlimb ischemia in diabetic mice$411,250
R01 · FY2011 · HL · contact PI
Mesenchymal stem cells in the treatment of hindlimb ischemia in diabetic mice$411,250
R01 · FY2010 · HL · contact PI
OVEREXPRESSION OF ENOS IN CRITICAL LIMB ISCHEMIA$507,824
R01 · FY2008 · HL · contact PI
OVEREXPRESSION OF ENOS IN CRITICAL LIMB ISCHEMIA$385,198
R01 · FY2007 · HL · contact PI
OVEREXPRESSION OF ENOS IN CRITICAL LIMB ISCHEMIA$369,849
R01 · FY2006 · HL · contact PI
OVEREXPRESSION OF ENOS IN CRITICAL LIMB ISCHEMIA$378,750
R01 · FY2005 · HL
OVEREXPRESSION OF ENOS IN CRITICAL LIMB ISCHEMIA$378,750
R01 · FY2004 · HL